European Patent EP4262629A1 for Valvular Regurgitation Treatment
Summary
The European Patent Office has published patent application EP4262629A1 for a device, system, and method for treating valvular regurgitation. The patent was applied for by Polares Medical Inc. and is designated for use in multiple European countries.
What changed
The European Patent Office (EPO) has published patent application EP4262629A1, titled "DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION WITH SECONDARY ANCHORS." This publication relates to novel medical technology for treating valvular regurgitation, with Polares Medical Inc. listed as the applicant. The patent is designated for use across numerous European states.
This patent publication represents a new intellectual property filing and does not impose immediate regulatory obligations on regulated entities. Compliance officers should note this as a development in medical device technology within the prosthetics and cardiovascular treatment sectors. No compliance actions or deadlines are associated with this patent publication itself.
Source document (simplified)
DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION WITH SECONDARY ANCHORS
Publication EP4262629A1 Kind: A1 Mar 11, 2026
Applicants
Polares Medical Inc.
Inventors
KHAIRKHAHAN, Alexander K., ESSINGER, Jacques, KLENK, Alan
IPC Classifications
A61F 2/24 20060101AFI20240924BHEP A61B 17/068 20060101ALI20240924BHEP A61B 17/064 20060101ALI20240924BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.